c="electrophoretic systems" 2:47 2:48||t="treatment"||cui="C1322091"||tot="Electrophoresis Systems"||ns="-1000"
c="abnormality" 2:64 2:64||t="problem"||cui="C0000768"||tot="Congenital Abnormality"||ns="-1000"
c="tryptic" 2:75 2:75||t="medication"||cui="C0041236"||tot="TRYPSIN"||ns="-928"
c="Its sequential analysis" 2:126 2:128||t="test"||cui="C0002778"||tot="Analysis of substances"||ns="-861"
c="glycine 119" 2:135 2:136||t="medication"||cui="C0017890"||tot="Glycine"||ns="-861"
c="other Hb" 2:177 2:178||t="problem"||cui="C1955473"||tot="Others"||ns="-661"
c="Hb Fannin-Lubbock beta 119 Gly" 2:185 2:189||t="medication"||cui="C0017890"||tot="Glycine"||ns="-799"
